Skip to main content
OpenTrials

Clinical trial condition

NASH/MASH

Explore clinical trials studying NASH/MASH. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

NASH/MASH trial results

Active, Not Recruiting

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT06161571

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations
  • Akero Clinical Study Site Birmingham, Alabama, United States
  • Akero Clinical Study Site Chandler, Arizona, United States
  • Akero Clinical Study Site Flagstaff, Arizona, United States
  • Akero Clinical Study Site Peoria, Arizona, United States
View all 211 locations
View Trial Details

Related conditions